BET-inhibitors as sensitizers for BH3-mimetics

Aging (Albany NY). 2017 Jun 26;9(6):1475-1476. doi: 10.18632/aging.101259.

Authors

Chiaki Tsuge Ishida¹, Georg Karpel-Massler², Markus D Siegelin¹

Affiliations

¹ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.
² Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany.

No abstract available

Keywords: BH3-mimetics; Bromodomain Extraterminal domain proteins inhibitors; cancer; cell death; drug combination therapies.

Publication types

Editorial
Comment

MeSH terms

Glioma*
Humans
Proto-Oncogene Proteins c-bcl-2

Substances

Proto-Oncogene Proteins c-bcl-2